Coupons and patient assistance programs from drug makers are proving to be an uncertain and often questionable way for patients to afford increasingly expensive specialty and brand name drugs.
Sponsored by Gruening Health & Wealth
Coupons and patient assistance programs from drug makers are proving to be an uncertain and often questionable way for patients to afford increasingly expensive specialty and brand name drugs.